Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 10, 2008 2:49:18 PM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Pfizer Down 77% on Loss of Exubera

Posted Oct 18, 07 7:54 AM CDT in Science & Health,  Business 

(Newser) – The world's largest drug maker took a 77% hit in third-quarter net income after dropping Exubera, its inhaled insulin product. Competition from generic drugs also pulled down sales, Pfizer announced this morning, as the company lowered its 2007 net-income forecast.

In walking away from Exubera, which Pfizer acquired the world-wide rights to last year for $1.4 billion, the company took a $2.8 billion charge. Sales were disappointing—just $4 million for the second quarter of 2007—the company said, as the drug "failed to gain the acceptance of patients and physicians." Sales of Lipitor, Zithromax, Zoloft, and Norvasc all suffered from recent loss of exclusivity.

Source Wall Street Journal

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Early Drug Regimen Helps Diabetics Later: Study

    Sep 10, 08 12:49 PM CDT
    Early Drug Regimen Helps Diabetics Later: Study A new study pushes for early, rigorous drug treatment of diabetes, even in people diagnosed with reversible type 2, Reuters reports. Diabetics given an intense drug regimen soon after diagnosis reduce their risk of heart attacks and reap long-term benefits from that medical attention, even if they become less mindful of controlling blood sugar later on. More »

  • 24M Americans Diabetic: CDC

    Jun 24, 08 4:39 PM CDT
    24M Americans Diabetic: CDC Almost 8% of the US population has diabetes, the government reported today. About 24 million Americans suffer from type-1 or -2 diabetes, an increase of 3 million since 2005, Reuters notes. Another 57 million Americans are pre-diabetic, a condition of insulin insensitivity that predisposes them to type-2 diabetes, the Centers for Disease Control and Prevention found. More »

  • Quit-Smoking Drug Linked to Heart Trouble, Dizziness

    May 22, 08 7:39 AM CDT
    Quit-Smoking Drug Linked to Heart Trouble, Dizziness Pfizer smoking-cessation drug Chantix has been linked to nearly a thousand serious incidents in the last quarter of 2007, the Wall Street Journal reports. A report from a drug safety group found that some users of the drug—already linked to depression and suicide—suffered heart trouble, diabetes, or accidents caused by dizziness and confusion. More »

  • Bypass Surgery Shows Promise as Diabetes Fix

    May 4, 08 10:09 AM CDT
    Bypass Surgery Shows Promise as Diabetes Fix Intestinal bypass surgery—a variation on the gastric surgery used to combat obesity—is showing surprising and promising results in treating diabetes, the Washington Post reports. Cutting out some of the intestine but sparing the stomach, the procedure is  producing full remission in a high percentage of cases, allowing patients to go off all medication.
    More »

  • Frogs Offer Hope to Diabetics

    Mar 3, 08 1:15 PM CST
    Frogs Offer Hope to Diabetics A frog that lives in the Amazon secretes a substance that stimulates insulin release in humans, offering new hope to diabetics, the BBC reports. The South American shrinking frog, which grows smaller as it ages, produces pseudin-2 through its slimy skin. A synthetic version of the peptide worked even better than the real thing in lab tests conducted by scientists in Northern Ireland and the UAE. More »

Pedestrians walk past Pfizer world headquarters in New York, in this Dec. 4, 2006 file photo. Pfizer Inc., the world's largest drug maker, said Friday, April 20, 2007 its profit fell 18 percent in the...   (Associated Press)
Pfizer world headquarters is seen in a New York file photo from Dec. 4, 2006. Nigerian government lawyers withdrew a $7 billion civil lawsuit against Pfizer Inc. on Friday, July 20, 2007, saying they...   (Associated Press)
The world headquarters of Pfizer Inc. is seen in New York in this April 12, 2005 file photo. Pfizer Chief Executive Jeffrey Kindler proved even those at the top aren't immune to an ongoing company-wide...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow

Threads (
1
 of 2)

Tags

diabetes  • Pfizer  • pharmaceutical  • insulin


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Business Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »